BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 7636977)

  • 1. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.
    Henderson AJ; Zou X; Calame KL
    J Virol; 1995 Sep; 69(9):5337-44. PubMed ID: 7636977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
    Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
    J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
    Ross HL; Gartner S; McArthur JC; Corboy JR; McAllister JJ; Millhouse S; Wigdahl B
    J Neurovirol; 2001 Jun; 7(3):235-49. PubMed ID: 11517398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.
    Schwartz C; Catez P; Rohr O; Lecestre D; Aunis D; Schaeffer E
    J Virol; 2000 Jan; 74(1):65-73. PubMed ID: 10590092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
    Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
    J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
    Burdo TH; Gartner S; Mauger D; Wigdahl B
    J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
    Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
    Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.
    Honda Y; Rogers L; Nakata K; Zhao BY; Pine R; Nakai Y; Kurosu K; Rom WN; Weiden M
    J Exp Med; 1998 Oct; 188(7):1255-65. PubMed ID: 9763605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
    Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
    DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
    Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
    J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
    Dahiya S; Liu Y; Nonnemacher MR; Dampier W; Wigdahl B
    PLoS One; 2014; 9(2):e88116. PubMed ID: 24551078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
    Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
    J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat.
    Nonnemacher MR; Hogan TH; Quiterio S; Wigdahl B; Henderson A; Krebs FC
    Biomed Pharmacother; 2003 Jan; 57(1):34-40. PubMed ID: 12642035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.
    Ambrosino C; Ruocco MR; Chen X; Mallardo M; Baudi F; Trematerra S; Quinto I; Venuta S; Scala G
    J Biol Chem; 1997 Jun; 272(23):14883-92. PubMed ID: 9169458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.
    Henderson AJ; Connor RI; Calame KL
    Immunity; 1996 Jul; 5(1):91-101. PubMed ID: 8758898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
    Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
    Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.